INT229906

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.51
First Reported 2008
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 2
Disease Relevance 1.29
Pain Relevance 1.84

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cell adhesion (Cd9)
Anatomy Link Frequency
brain 2
Cd9 (Rattus norvegicus)
Pain Link Frequency Relevance Heat
Neuropeptide 8 99.88 Very High Very High Very High
long-term potentiation 10 98.48 Very High Very High Very High
Hippocampus 4 98.26 Very High Very High Very High
Spinal cord 30 91.32 High High
central sensitization 2 90.56 High High
Pain 78 88.68 High High
Inflammation 76 82.64 Quite High
Glutamate receptor 2 50.64 Quite High
Hyperalgesia 46 50.00 Quite Low
Glutamate 2 47.12 Quite Low
Disease Link Frequency Relevance Heat
Pain 116 88.68 High High
INFLAMMATION 84 82.64 Quite High
Neurodegenerative Disease 10 72.16 Quite High
Nociception 4 66.32 Quite High
Hyperalgesia 54 50.00 Quite Low
Inflammatory Pain 6 42.96 Quite Low
Injury 10 5.00 Very Low Very Low Very Low
Frailty 6 5.00 Very Low Very Low Very Low
Nervous System Injury 4 5.00 Very Low Very Low Very Low
Neuropathic Pain 4 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
We have found that a number of genes altered at 28d were also altered in the hippocampus during LTP: brain-derived neurotrophic factor (BDNF), early growth response 1 (EGR1), CD9 antigen (CD9), neuropeptide Y receptor Y5 (NPY5R), and neuropeptide Y receptor (NPY1R) [41].
Gene_expression (antigen) of CD9 in brain associated with neuropeptide, long-term potentiation and hippocampus
1) Confidence 0.51 Published 2008 Journal BMC Neurosci Section Body Doc Link PMC2315656 Disease Relevance 0.64 Pain Relevance 0.92
We have found that a number of genes altered at 28d were also altered in the hippocampus during LTP: brain-derived neurotrophic factor (BDNF), early growth response 1 (EGR1), CD9 antigen (CD9), neuropeptide Y receptor Y5 (NPY5R), and neuropeptide Y receptor (NPY1R) [41].
Gene_expression (antigen) of CD9 in brain associated with neuropeptide, long-term potentiation and hippocampus
2) Confidence 0.51 Published 2008 Journal BMC Neurosci Section Body Doc Link PMC2315656 Disease Relevance 0.64 Pain Relevance 0.92

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox